| Basics |
Medpace Holdings, Inc.
Medpace Holdings Inc is a clinical contract research organisation. It is engaged in providing scientifically-driven clinical research-based drug and medical device development services to the biotechnology, pharmaceutical and medical device industries.
|
| IPO Date: |
August 11, 2016 |
| Sector: |
Healthcare |
| Industry: |
Medical Diagnostics and Research |
| Market Cap: |
$8.58B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$2.47 | 1.64%
|
| Avg Daily Range (30 D): |
$5.47 | 1.86%
|
| Avg Daily Range (90 D): |
$5.90 | 1.91%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.27M |
| Avg Daily Volume (30 D): |
.42M |
| Avg Daily Volume (90 D): |
.37M |
| Trade Size |
| Avg Trade Size (Sh.): |
48 |
| Avg Trade Size (Sh.) (30 D): |
32 |
| Avg Trade Size (Sh.) (90 D): |
31 |
| Institutional Trades |
| Total Inst.Trades: |
2,898 |
| Avg Inst. Trade: |
$5.4M |
| Avg Inst. Trade (30 D): |
$11M |
| Avg Inst. Trade (90 D): |
$10.89M |
| Avg Inst. Trade Volume: |
.04M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$6.52M |
| Avg Closing Trade (30 D): |
$12.2M |
| Avg Closing Trade (90 D): |
$11.86M |
| Avg Closing Volume: |
40.56K |
|
|
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$13.51
|
$3.77
|
$3.78
|
|
Diluted EPS
|
$13.1
|
$3.67
|
$3.67
|
|
Revenue
|
$ 2.16B
|
$ 558.57M
|
$ 536.59M
|
|
Gross Profit
|
$ 679.51M
|
$ 178.35M
|
$ 178.32M
|
|
Net Income / Loss
|
$ 416.39M
|
$ 114.6M
|
$ 117.02M
|
|
Operating Income / Loss
|
$ 456.32M
|
$ 113.52M
|
$ 125.38M
|
|
Cost of Revenue
|
$ 1.48B
|
$ 380.22M
|
$ 358.27M
|
|
Net Cash Flow
|
$ 34.43M
|
$ -228M
|
$ 12.54M
|
|
PE Ratio
|
22.65
|
|
|
|
